Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone Lymphoma (MZL...
Check out the Top Ten most popular articles on Pharmafile.com this week!
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of the UK R&D Consultative Committee discusses the importance...
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission.

Features

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its biggest stories, according to our readers.

Appointments

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax,...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches